Our Vision
To lead as a research-driven, globally recognised pharmaceutical API company committed to quality and stability in product supply
Our Mission
Pioneering a future
where possibilities know
no boundaries or limits
Our Mission
Pioneering a future
where possibilities know
no boundaries or limits
Offer cost-effective, high-quality API development and delivery
Establish our presence in the global pharmaceutical supply chain
Commit to Environmental, Health, Safety (EHS) compliance and continuous cost optimisation
Expand into new markets and therapy areas
Foster an inspiring and rewarding work culture
Our Values
Core principles shaping us
Customer Centricity
Customer-first approach fostering collaborative partnerships
Integrity
Rooted in honesty and trust, nurturing a culture of excellence
Cost Innovation
Driving cost-effective production through continuous research and innovation
Respect
Valuing our employees' skills, dedication, and motivation while cultivating a culture of recognition
Milestones
Key milestones in our growth journey
Q3 2021
Valence established as greenfield project for APIs and Advanced Intermediates
Q2 2022
Began R&D operations
Began plant construction after securing all requisite government approvals
Q4 2023
Secured Drug Manufacturing License and state GMP certification
Started product validation batches at the newly constructed pilot plant
Q1 2024
First Manufacturing Block (150 KL) equipment installation & start of production
Q3 2024
WHO GMP Certification
First CEP Filling
Written confirmation for export to Europe
Q4 2024
EDQM Certification
PMDA Certification
KFDA Certification
Q1 2025
ANVISA Certification
COFEPRIS Certification
US DMF Filling
CEP Approval
Q2 2025
2nd Manufacturing Block
(200 KL) commissioningUS FDA Inspection and Approval
Q4 2025
Oncology Block Commissioning
Q3 2026
Fermentation Block Commissioning
Milestones
Key milestones in our growth journey
